P130 Treatment of intermediate and high risk myelodysplastic syndrome patients with azacitidine. The Hellenic experience

Autor: Pappa, V., Papageorgiou, S., Tsirigotis, P., Dervenoulas, J., Girkas, K., Papageorgiou, E., Poulakidas, H., Papadaki, E., Galanopoulos, A., Vervessou, E., Panayotidis, P., Zomas, A., Symeonidis, A., Economopoulos, T.

Publikováno v: In Leukemia Research 2009 33 Supplement 1:S134-S135

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Simeprevir and Sofosbuvir Combination Treatment in a Patient with HCV Cirrhosis and HbS Beta 0-Thalassemia: Efficacy and Safety despite Baseline Hyperbilirubinemia.

Autor: Papadopoulos N; First Department of Internal Medicine, 401 General Army Hospital of Athens, 11525 Athens, Greece., Deutsch M; Second Department of Internal Medicine, Athens University Medical School, Hippokration Hospital of Athens, 11527 Athens, Greece., Georgalas A; First Department of Internal Medicine, 401 General Army Hospital of Athens, 11525 Athens, Greece., Poulakidas H; Hematology Department, 401 General Army Hospital of Athens, 11525 Athens, Greece., Karnesis L; First Department of Internal Medicine, 401 General Army Hospital of Athens, 11525 Athens, Greece.

Publikováno v: Case reports in hematology [Case Rep Hematol] 2016; Vol. 2016, pp. 7635128. Date of Electronic Publication: 2016 Mar 02.